Nepsone ehf
- Biotech or pharma, therapeutic R&D
Nepsone is an early stage pharmaceutical company for dermatology diseases due to an imbalance in the autonomic nervous system. Leading indication: topical psoriasis. Pipeline includes: eczema, alopecia areata, and wound healing. Seeking Series A $5.5 m.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}